Archive for June, 2015
Recent Rosacea Blog Posts
This article details some modest benefits to rosacea symptoms experienced by users of 3% topical tranexamic acid. Trialists of the active topical experienced an improvement in stratum corneum function and in “clinical signs and symptoms of rosacea”. The authors further detail a suggested pathway of how tranexaminc acid benfits rosacea. See the full text link […]
LEFT: Patient at initial clinic visit after 7 months of brimonidine treatment showing compensatory vasodilation and flushing in untreated areas of right lateral cheek and chest. RIGHT: Patient 1 week after cessation of brimonidine treatment showing marked improvement in compensatory vasodilation and flushing. A brief observation published in the Journal of American Medical Association Dermatology […]
Promius Pha rma, a subsidiary of Dr. Reddy’s Laboratory has filed a New Drug Application for a modified release tetracycline for the treatment of rosacea. Promius is calling their new drug DFD-09. Promius Pharma is probably best know to rosacea sufferers via the availability of Promiseb Topical Cream in the US. Promiseb, a treatment for […]
Following on from the large trial announcement by Actavis last year, Galderma has started a suit against Actavis to prevent the sale of Generic Mirvaso. Actavis has filed an abbreviated new drug application with the FDA. Galderma is seeking to use a series of patents to block Actavis from marketing their Brimonidine Topical Gel, 0.33%. […]
As announced in March, Soolantra has been approved for sale in Europe. The official prescribing information for Soolantra in the EEA has been published. The names are all pretty obvious – making it clear why Galderma would invent a new name for their product. The only exception is that Soolantra will be known as Vastreka […]
